Actively Recruiting
Confounding Factors of Chronic Endometritis in Women With Reproductive Failure
Led by Chinese University of Hong Kong · Updated on 2025-03-27
720
Participants Needed
1
Research Sites
261 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the study is to investigate the confounding factors of chronic endometritis and therapeutic benefits of antibodies targeting plasma cells in women with reproductive failure.
CONDITIONS
Official Title
Confounding Factors of Chronic Endometritis in Women With Reproductive Failure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 20-45 years
- History of 2 or more consecutive miscarriages before 24 weeks of gestation
- Failure to conceive after one year of unprotected intercourse
- Failure to achieve clinical pregnancy after two consecutive IVF, ICSI, or frozen embryo replacement cycles, with sufficient transferred good-quality embryos
You will not qualify if you...
- Uncorrected uterine abnormalities like septate or bicornuate uterus, or fibroids
- Untreated hydrosalpinx
- History of antiphospholipid syndrome
- Known autoimmune diseases
- Currently receiving immunotherapy
- Abnormal thyroid function
- Abnormal karyotyping
- Active pelvic inflammatory disease or suspected infection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Chinese University of Hong Kong
Hong Kong, Hong Kong
Actively Recruiting
Research Team
S
Stacey Wong, BSc
CONTACT
J
JacquelinePui Wah Chung, MBBS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here